BAI1-Associated Protein 2-Like 1 (BAIAP2L1) Is a Potential Biomarker in Ovarian Cancer.

PubWeight™: 0.76‹?›

🔗 View Article (PMC 4519316)

Published in PLoS One on July 29, 2015

Authors

Angel Chao1, Chia-Lung Tsai2, Shih-Ming Jung3, Wei-Chi Chuang4, Chieh Kao4, An Hsu4, Shun-Hua Chen4, Chiao-Yun Lin1, Yi-Chao Lee5, Yun-Shien Lee6, Tzu-Hao Wang7, Hsin-Shih Wang1, Chyong-Huey Lai1

Author Affiliations

1: Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan.
2: Genomic Medicine Research Core Laboratory, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
3: Department of Clinical Pathology, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan.
4: Graduate Institute of Biomedical Science, School of Medicine, Chang Gung University, Taoyuan, Taiwan.
5: College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.
6: Genomic Medicine Research Core Laboratory, Chang Gung Memorial Hospital, Taoyuan, Taiwan; Department of Biotechnology, Ming-Chuan University, Taoyuan, Taiwan.
7: Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan; Genomic Medicine Research Core Laboratory, Chang Gung Memorial Hospital, Taoyuan, Taiwan; School of Traditional Chinese Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan.

Articles cited by this

Global cancer statistics. CA Cancer J Clin (2011) 185.92

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature (2012) 31.78

BAR domains as sensors of membrane curvature: the amphiphysin BAR structure. Science (2003) 12.60

A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med (1983) 8.82

Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest (1981) 6.89

PI3K and cancer: lessons, challenges and opportunities. Nat Rev Drug Discov (2014) 4.81

The CA 125 tumour-associated antigen: a review of the literature. Hum Reprod (1989) 4.13

Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer (2013) 4.02

Targeting cellular metabolism to improve cancer therapeutics. Cell Death Dis (2013) 3.07

Cancer cell metabolism: one hallmark, many faces. Cancer Discov (2012) 3.03

Oncogenic FGFR3 gene fusions in bladder cancer. Hum Mol Genet (2012) 2.35

Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides. Nature (2014) 2.27

Latest research and treatment of advanced-stage epithelial ovarian cancer. Nat Rev Clin Oncol (2013) 2.24

IRSp53: crossing the road of membrane and actin dynamics in the formation of membrane protrusions. Trends Cell Biol (2008) 1.99

A novel actin bundling/filopodium-forming domain conserved in insulin receptor tyrosine kinase substrate p53 and missing in metastasis protein. J Biol Chem (2004) 1.96

Moderate progress for ovarian cancer in the last 20 years: prolongation of survival, but no improvement in the cure rate. Eur J Cancer (2002) 1.77

Gene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cells. BMC Med Genomics (2009) 1.55

Patterns and progress in ovarian cancer over 14 years. Obstet Gynecol (2006) 1.52

Enterohaemorrhagic Escherichia coli exploits a tryptophan switch to hijack host f-actin assembly. Structure (2012) 1.47

Insulin receptor tyrosine kinase substrate links the E. coli O157:H7 actin assembly effectors Tir and EspF(U) during pedestal formation. Proc Natl Acad Sci U S A (2009) 1.46

Gain-of-function of poly(ADP-ribose) polymerase-1 upon cleavage by apoptotic proteases: implications for apoptosis. J Cell Sci (2001) 1.43

Characterisation of IRTKS, a novel IRSp53/MIM family actin regulator with distinct filament bundling properties. J Cell Sci (2007) 1.42

Gene expression profiling in the human hypothalamus-pituitary-adrenal axis and full-length cDNA cloning. Proc Natl Acad Sci U S A (2000) 1.33

Distinctive gene expression signatures in rheumatoid arthritis synovial tissue fibroblast cells: correlates with disease activity. Genes Immun (2007) 1.32

A genome-wide association meta-analysis of circulating sex hormone-binding globulin reveals multiple Loci implicated in sex steroid hormone regulation. PLoS Genet (2012) 1.23

Discrimination between benign and malignant adnexal masses by specialist ultrasound examination versus serum CA-125. J Natl Cancer Inst (2007) 1.22

C-reactive protein as a biomarker for urological cancers. Nat Rev Urol (2011) 1.21

Molecular characterization of adenocarcinoma and squamous carcinoma of the uterine cervix using microarray analysis of gene expression. Int J Cancer (2006) 1.11

Stress-induced phosphoprotein 1 as a secreted biomarker for human ovarian cancer promotes cancer cell proliferation. Mol Cell Proteomics (2010) 1.06

Recognition of tandem PxxP motifs as a unique Src homology 3-binding mode triggers pathogen-driven actin assembly. Proc Natl Acad Sci U S A (2010) 1.04

Src-stimulated IRTKS phosphorylation enhances cell migration. FEBS Lett (2011) 0.94

Insulin receptor tyrosine kinase substrate enhances low levels of MDM2-mediated p53 ubiquitination. PLoS One (2011) 0.91

Tumor stress-induced phosphoprotein1 (STIP1) as a prognostic biomarker in ovarian cancer. PLoS One (2013) 0.87

Analysis of functional groups of differentially expressed genes in the peripheral blood of patients with cervical cancer undergoing concurrent chemoradiation treatment. Radiat Res (2008) 0.87

Structural basis for complex formation between human IRSp53 and the translocated intimin receptor Tir of enterohemorrhagic E. coli. Structure (2011) 0.85

Insulin receptor tyrosine kinase substrate activates EGFR/ERK signalling pathway and promotes cell proliferation of hepatocellular carcinoma. Cancer Lett (2013) 0.85

Deficiency of IRTKS as an adaptor of insulin receptor leads to insulin resistance. Cell Res (2013) 0.83

Mechanism of Oncogenic Signal Activation by the Novel Fusion Kinase FGFR3-BAIAP2L1. Mol Cancer Ther (2015) 0.83

Enterohemorrhagic Escherichia coli raises the I-BAR. Proc Natl Acad Sci U S A (2009) 0.79